Journal article
Associations of serum adiponectin with markers of cardio-metabolic disease risk in Indigenous Australian adults with good health, diabetes and chronic kidney disease
JT Hughes, K O'Dea, K Piera, F Barzi, A Cass, WE Hoy, RJ MacIsaac, LJ Maple-Brown
Obesity Research and Clinical Practice | ELSEVIER SCI LTD | Published : 2016
Abstract
The higher serum adiponectin concentrations observed in females are often attributed to differences in adiposity or sex hormones. There is little data describing adiponectin in Indigenous Australians, and no studies examining its association with cardio-metabolic disease risk markers and chronic kidney disease (CKD). Aim To describe the relationship of serum adiponectin with cardio-metabolic disease risk markers and kidney function in a community-based sample of Indigenous Australian adults, with particular reference to sex-specific differences. Methods A cross-sectional analysis of a community-based volunteer sample of 548 Indigenous Australian adults (62% female), stratified into five card..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The eGFR Study was funded by the National Health and Medical Research Council (NHMRC; project grant 545202), Sea-Swift Thursday Island. Leptin and Adiponectin assay kits were supported by CVL Pfizer Research Grant. J.H. was supported by NHMRC ECF 1092576 and formerly by scholarship 490348, Jacquot Research Establishment Award; KP was supported by NHMRC Program Grant 490307; L.M-B. was supported by NHMRC Fellowship 605837 and NHMRC Practitioner Fellowship 1078477.